Get started
Author

Alexander Hallner

Observed name: A Hallner
ORCID: 0000-0002-4973-5097
Observed ORCID: 0000-0002-4973-5097
OpenAlex ID: A5089535768
The HLA-B −21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia
2019 · Alexander Hallner, Elin Bernson, et al. · Blood · 63
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease
2018 · Ebru Aydin, Alexander Hallner, et al. · Oncogene · 39
PDF
Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells
2016 · Olle Werlenius, Johan Aurelius, et al. · Oncotarget · 29
PDF
NOX2-dependent immunosuppression in chronic myelomonocytic leukemia
2017 · Johan Aurelius, Alexander Hallner, et al. · Journal of Leukocyte Biology · 25
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
2019 · Malin S. Nilsson, Alexander Hallner, et al. · Human Vaccines & Immunotherapeutics · 23
PDF
Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species
2020 · Ali A. Akhiani, Alexander Hallner, et al. · Cancer Immunology Research · 19
Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia
2017 · E Bernson, A Hallner, et al. · Leukemia · 19
PDF
Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia
2017 · Anna Rydstroüm, Alexander Hallner, et al. · Journal of Leukocyte Biology · 18
NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells
2023 · Brwa Ali Hussein, Linnea Kristenson, et al. · Journal for ImmunoTherapy of Cancer · 12
PDF
Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
2021 · Brwa Ali Hussein, Alexander Hallner, et al. · Frontiers in Immunology · 11
PDF
Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
2019 · Malin S. Nilsson, Alexander Hallner, et al. · British Journal of Haematology · 11
PDF
Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2018 · Elin Bernson, Alexander Hallner, et al. · Cancer Immunology Research · 9
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
2017 · Anna Wenger, Katja Werlenius, et al. · Neoplasia · 9
PDF
Immunotherapy with histamine dihydrochloride and low‐dose interleukin‐2 favors sustained lymphocyte recovery in acute myeloid leukemia
2014 · Alexander Hallner, Johan Aurelius, et al. · European Journal Of Haematology · 4
PDF
HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia
2023 · Hana Komic, Alexander Hallner, et al. · Cancer Immunology Immunotherapy · 3
PDF
Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
2022 · Brwa Ali Hussein, Alexander Hallner, et al. · Frontiers in Immunology · 2
PDF
Data from Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species
2023 · Ali A. Akhiani, Alexander Hallner, et al.
Data from Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species
2023 · Ali A. Akhiani, Alexander Hallner, et al.
Figures S1-S8, Table S1 from Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species
2023 · Ali A. Akhiani, Alexander Hallner, et al.
Figures S1-S8, Table S1 from Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species
2023 · Ali A. Akhiani, Alexander Hallner, et al.
Data from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
Supplementary information from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
Supplementary information from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
PDF
Data from Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2023 · Elin Bernson, Alexander Hallner, et al.
Complete Remission after the First Cycle of Induction Chemotherapy Determines the Clinical Efficacy of Relapse-Preventive Immunotherapy in Acute Myeloid Leukemia
2019 · Malin S Nilsson, Alexander Hallner, et al. · Blood
Works count: 28
Citation count: 296
H-index: 11
I10-index: 11
Year
Topic
Type